A recent cohort study found that adverse childhood experiences (ACEs) are strongly associated with treatment-resistant depression (TRD), even after accounting for familial and genetic confounding.
Selective serotonin reuptake inhibitors (SSRIs) are associated with a significantly increased risk of sexual dysfunction in adults treated for depression, according to a systematic review and...
As seen in a recent interview with Psych Congress Scientific Director Craig Chepke, MD, DFAPA, kappa receptor antagonists have shown potential as a treatment to target which MDD symptom?
Veronica Ridpath, DO, Psych Congress Elevate faculty member, discusses how evolving understanding of the biological pathways involved in depression is changing the landscape of treatment approaches.
In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in depression treatment.
A recent cohort study found that adverse childhood experiences (ACEs) are strongly associated with treatment-resistant depression (TRD), even after accounting for familial and genetic confounding.
Selective serotonin reuptake inhibitors (SSRIs) are associated with a significantly increased risk of sexual dysfunction in adults treated for depression, according to a systematic review and...
Racemic ketamine was noninferior to intranasal esketamine for reducing depressive symptoms in adults with treatment-resistant depression (TRD) over 4 weeks.
A new systematic review and network meta-analysis has found that slow antidepressant tapering combined with psychological support is as effective as continuation therapy in preventing relapse in adults with...